|Articles|August 25, 2015

Bill to Modernize FDA Communication

Author(s)Applied Clinical Trials Editorial Staff

U.S. Representative Billy Long has introduced legislation to update regulations guiding how drug manufacturers communicate product information.

U.S. Representative Billy Long (R-MO 7th District) has introduced legislation to update regulations guiding how drug manufacturers communicate product information. Long is the lead sponsor of H.R. 2479, which would ensure the FDA clearly regulated meaningful, truthful and non-misleading communication of product information on social media.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!